Sebastien Maloveste
Corporate Officer/Principal en NEXTCURE, INC. .
Perfil
Sebastien Maloveste is currently working as the Senior Vice President-Business Development at NextCure, Inc. Previously, he held positions as the Director-Business Development at GenVec, Inc. and as the Associate Director-Business Development at Amplimmune, Inc. Dr. Maloveste obtained a doctorate degree from Universite De La Mediterranee.
Cargos activos de Sebastien Maloveste
| Empresas | Cargo | Inicio |
|---|---|---|
| NEXTCURE, INC. | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Sebastien Maloveste.
| Empresas | Cargo | Fin |
|---|---|---|
Amplimmune, Inc.
 Amplimmune, Inc. BiotechnologyHealth Technology Amplimmune, Inc. develops immune-based biological treatment for cancer and autoimmune diseases. The company was founded by Michael Richman, Charles G. Drake, Andrea Cox, Drew M. Pardoll, Jonathan D. Powell, Lieping Chen, David S. Kabakoff, and Elizabeth Jaffee in 2007 and is headquartered in Gaithersburg, MD. | Corporate Officer/Principal | - |
| GENVEC INC | Corporate Officer/Principal | - |
Formación de Sebastien Maloveste.
| Universite De La Mediterranee | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| NEXTCURE, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
GenVec, Inc.
 GenVec, Inc. Pharmaceuticals: MajorHealth Technology GenVec, Inc. operated as a clinical-stage gene delivery company, which engaged in the development of therapeutics and vaccines. The firm designs, tests, and manufactured adenoviral-based product candidates using its proprietary AdenoVerse platform. Its products included CGF166-Hearing Loss; GV2311-RSV Vaccine; and GV2207-HSV-2 Immunotherapeutic. The company was founded in December 1992 and was headquartered in Rockville, MD. | Health Technology |
Amplimmune, Inc.
Amplimmune, Inc. BiotechnologyHealth Technology Amplimmune, Inc. develops immune-based biological treatment for cancer and autoimmune diseases. The company was founded by Michael Richman, Charles G. Drake, Andrea Cox, Drew M. Pardoll, Jonathan D. Powell, Lieping Chen, David S. Kabakoff, and Elizabeth Jaffee in 2007 and is headquartered in Gaithersburg, MD. | Health Technology |
- Bolsa de valores
- Insiders
- Sebastien Maloveste
